News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

Graham Bell

Advertisement

Director, Global Regulatory Strategy, ICON plc

Articles by Graham Bell

Preparing to Achieve with Joint Clinical Assessments

ByGraham Bell
June 11th 2025

Strategies for sponsors in navigating the European Union's new health technology assessment regulation.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Applied Clinical Trials Online

    1

    Reasoning About Individual Drug Causality in a Multifactorial World

    2

    BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal

    3

    ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication

    4

    ACT Brief: EU Comparator Drug Sourcing Pressures, AI Expands Its Role in Oncology Trials, and Rethinking AI Value in Clinical Development

    5

    Why Trial Competition Is Undermining AI-Driven Gains

    • About
    • Advertise
    • Contact Us
    • Editorial Contacts
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Applied Clinical Trials
    • BioPharm International
    • Cannabis Science and Technology
    • Chromatography Online
    • Nutritional Outlook
    • Pharmaceutical Commerce
    • Pharmaceutical Executive
    • Pharm Tech
    • Spectroscopy Online
    • Turbo Machinery Magazine
    IS1
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us